Cymabay Therapeutics

Cymabay Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients with liver and other chronic diseases through a range of innovative therapies, addressing significant unmet medical needs. With a long history of drug discovery and development, we deliver value to all stakeholders by deeply understanding the underlying mechanisms of inflammation and fibrosis, unique targets involved in their progression, and innovative treatments for liver and chronic diseases.